#United States #Washington #Certification #ADLM #CMS

ADLM Opposes CMS Proposal on Laboratory Director Certification

On October 19, 2026, the Association for Diagnostics and Laboratory Medicine (ADLM) made headlines with a bold statement from its president, Dr. Stanley F. Lo. This statement was a response to a proposed rule by the Centers for Medicare & Medicaid Services (CMS) that aims to eliminate board certification requirements for those directing high-complexity clinical laboratories.

Dr. Lo articulated the concerns regarding the highest standards necessary for the effective operation of these laboratories, which are essential in our healthcare system. "High-complexity laboratories perform sophisticated testing that physicians depend on to diagnose diseases and guide treatment approaches," he stated. The role of laboratory directors is immensely significant; they are responsible for overseeing all clinical, scientific, and operational facets of laboratory activities.

Laboratories that perform complex tests play a pivotal role in patient care, making informed decisions on medical treatments based largely on test results. It is crucial that those directing these laboratories possess not only the academic qualifications but also the practical competency verified through independent board certification endorsed by the Department of Health and Human Services (HHS).

Under the new CMS proposal, laboratory directors would potentially meet federal requirements through just one year of experience in directing or supervising high-complexity testing, or by completing a mere 20 hours of continuing education related to their responsibilities. Dr. Lo argues that neither of these provisions provides the necessary independent assessment of specialized knowledge that formal board certification does. In his words, "Neither of these alternative measures is equivalent to the independent assessment of specialized knowledge that board certification provides."

The discussion surrounding this topic is critical as it addresses the balance between modernizing regulations and maintaining high standards in laboratory testing. While ADLM acknowledges the necessity of evolving to accommodate qualified scientists from diverse educational and professional backgrounds, it firmly believes that this should not compromise the quality and rigor expected of medical laboratory directors.

ADLM's statement emphasizes the necessity for rigorous standards in the qualifications of laboratory directors. They hold that directors need the ability to exercise independent scientific judgment and that, while collaboration with other qualified professionals is vital, the core accountability must lie with those in leadership positions.

The ADLM has been a steadfast advocate for advancements in laboratory medicine since its inception in 1948. With a community composed of over 70,000 professionals, including clinical laboratory scientists and physicians across 110 countries, their mission is to enhance health outcomes through collaboration and innovative practices in laboratory medicine.

As the conversation surrounding these regulatory proposals unfolds, it's evident that the ADLM is committed to championing the need for highly qualified laboratory directors equipped to support the healthcare system through quality laboratory services. They call on CMS to uphold the HHS-approved board certification requirement and reconsider any proposed changes that might dilute these standards.

In conclusion, ensuring high-quality healthcare is paramount, and with laboratory directors playing such a critical role in patient care, retaining comprehensive certification standards is a vital step towards safeguarding public health. For further information on ADLM and its initiatives, visit their official website at www.myadlm.org.